{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:49:42Z","timestamp":1790214582965,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01139-5","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T16:03:04Z","timestamp":1689955384000},"page":"3729-3736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Interactions and clinical implications of serological and respiratory variables 3\u00a0months after acute COVID-19"],"prefix":"10.1007","volume":"23","author":[{"given":"Ophir","family":"Freund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Breslavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotem","family":"Givoli-Vilensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Cohen-Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Zacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Kleinhendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avraham","family":"Unterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shir","family":"Frydman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Wand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Bilenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Bar-Shai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"issue":"9","key":"1139_CR1","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","volume":"226","author":"C Chen","year":"2022","unstructured":"Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593\u2013607.","journal-title":"J Infect Dis"},{"key":"1139_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101762","volume":"55","author":"LL O\u2019Mahoney","year":"2023","unstructured":"O\u2019Mahoney LL, Routen A, Gillies C, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55: 101762.","journal-title":"EClinicalMedicine"},{"issue":"9","key":"1139_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S2213-2600(20)30349-0","volume":"8","author":"G Raghu","year":"2020","unstructured":"Raghu G, Wilson KC. COVID-19 interstitial pneumonia: monitoring the clinical course in survivors. Lancet Respir Med. 2020;8(9):839\u201342.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"1139_CR4","doi-asserted-by":"publisher","first-page":"e221809","DOI":"10.1001\/jamahealthforum.2022.1809","volume":"3","author":"DM Cutler","year":"2022","unstructured":"Cutler DM. The Costs of Long COVID. JAMA Heal Forum. 2022;3(5):e221809\u2013e221809. https:\/\/doi.org\/10.1001\/jamahealthforum.2022.1809.","journal-title":"JAMA Heal Forum"},{"issue":"15","key":"1139_CR5","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/jama.2020.19759","volume":"324","author":"DM Cutler","year":"2020","unstructured":"Cutler DM, Summers LH. The COVID-19 pandemic and the $16 trillion virus. JAMA. 2020;324(15):1495\u20136. https:\/\/doi.org\/10.1001\/jama.2020.19759.","journal-title":"JAMA"},{"issue":"4","key":"1139_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jhm.13063","volume":"18","author":"O Freund","year":"2023","unstructured":"Freund O, Azolai L, Sror N, et al. Diagnostic delays among COVID-19 patients with a second concurrent diagnosis. J Hosp Med. 2023;18(4):321\u20138. https:\/\/doi.org\/10.1002\/jhm.13063.","journal-title":"J Hosp Med"},{"key":"1139_CR7","doi-asserted-by":"crossref","unstructured":"Anastasio F, Barbuto S, Scarnecchia E, et al. Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life. Eur Respir J. 2021;58(3).","DOI":"10.1183\/13993003.04015-2020"},{"issue":"6","key":"1139_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109518","volume":"36","author":"MJ Peluso","year":"2021","unstructured":"Peluso MJ, Deitchman AN, Torres L, et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36(6): 109518.","journal-title":"Cell Rep"},{"key":"1139_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2023.02.010","volume":"116","author":"A Chan","year":"2023","unstructured":"Chan A, Martinez-Cajas J, Yip PM, et al. Evaluation and comparison of four quantitative SARS-CoV-2 serological assays in COVID-19 patients and immunized healthy individuals, cancer patients, and patients with immunosuppressive therapy. Clin Biochem. 2023;116:1\u20136.","journal-title":"Clin Biochem"},{"issue":"6","key":"1139_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02537-22","volume":"10","author":"K Fogh","year":"2022","unstructured":"Fogh K, Larsen TG, Hansen CB, et al. Self-reported long COVID and its association with the presence of SARS-CoV-2 antibodies in a danish cohort up to 12 months after infection. Microbiol Spectr. 2022;10(6): e0253722.","journal-title":"Microbiol Spectr"},{"issue":"7","key":"1139_CR11","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10875-021-01083-7","volume":"41","author":"J Garc\u00eda-Abell\u00e1n","year":"2021","unstructured":"Garc\u00eda-Abell\u00e1n J, Padilla S, Fern\u00e1ndez-Gonz\u00e1lez M, et al. Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study. J Clin Immunol. 2021;41(7):1490\u2013501. https:\/\/doi.org\/10.1007\/s10875-021-01083-7.","journal-title":"J Clin Immunol"},{"key":"1139_CR12","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (CDC). Antibody testing interim guidelines for COVID-19 antibody testing in clinical and public health settings 2022 [cited 2023 Mar 4]. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/testing\/antibody-tests-guidelines.html.","DOI":"10.46234\/ccdcw2020.085"},{"key":"1139_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100463","volume":"25","author":"Y-M Zhao","year":"2020","unstructured":"Zhao Y-M, Shang Y-M, Song W-B, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25: 100463.","journal-title":"EClinicalMedicine"},{"issue":"10296","key":"1139_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(21)00799-6","volume":"398","author":"TM Drake","year":"2021","unstructured":"Drake TM, Riad AM, Fairfield CJ, et al. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet. 2021;398(10296):223\u201337.","journal-title":"Lancet"},{"key":"1139_CR15","unstructured":"National Institutes of Health. COVID-19 treatment guidelines [cited 2021 Jan 12]. https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"issue":"10270","key":"1139_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220\u201332.","journal-title":"Lancet"},{"key":"1139_CR17","doi-asserted-by":"publisher","first-page":"100122","DOI":"10.1016\/j.lanepe.2021.100122","volume":"6","author":"M Augustin","year":"2021","unstructured":"Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122.","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"1139_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-021-01727-7","volume":"22","author":"SA Guler","year":"2021","unstructured":"Guler SA, Wohlfarth E, Berezowska S, Geiser TK, Ebner L, Funke-Chambour M. Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case\u2013control study. Respir Res. 2021;22(1):1\u20137. https:\/\/doi.org\/10.1186\/s12931-021-01727-7.","journal-title":"Respir Res"},{"issue":"3","key":"1139_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bja.2021.11.024","volume":"128","author":"X Yang","year":"2022","unstructured":"Yang X, Li Z, Wang B, et al. Prognosis and antibody profiles in survivors of critical illness from COVID-19: a prospective multicentre cohort study. Br J Anaesth. 2022;128(3):491\u2013500.","journal-title":"Br J Anaesth"},{"issue":"3","key":"1139_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133\u201346. https:\/\/doi.org\/10.1038\/s41579-022-00846-2.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"1139_CR21","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1159\/000518141","volume":"100","author":"P Faverio","year":"2021","unstructured":"Faverio P, Luppi F, Rebora P, et al. Six-month pulmonary impairment after severe COVID-19: a prospective, multicentre follow-up study. Respiration. 2021;100(11):1078\u201387.","journal-title":"Respiration"},{"issue":"2","key":"1139_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41423-020-00588-2","volume":"18","author":"V Legros","year":"2021","unstructured":"Legros V, Denolly S, Vogrig M, et al. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity. Cell Mol Immunol. 2021;18(2):318\u201327. https:\/\/doi.org\/10.1038\/s41423-020-00588-2.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"1139_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/infdis\/jiaa659","volume":"223","author":"F Muecksch","year":"2021","unstructured":"Muecksch F, Wise H, Batchelor B, et al. Longitudinal serological analysis and neutralizing antibody levels in coronavirus disease 2019 convalescent patients. J Infect Dis. 2021;223(3):389\u201398.","journal-title":"J Infect Dis"},{"issue":"4","key":"1139_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/23744235.2023.2168047","volume":"55","author":"O Freund","year":"2023","unstructured":"Freund O, Weiss TE, Tau L, et al. Safety and outcomes of an early discharge strategy with oxygen home therapy in stable severe COVID-19 patients. Infect Dis (Lond, Engl). 2023;55(4):292\u20138.","journal-title":"Infect Dis (Lond, Engl)"},{"issue":"5","key":"1139_CR25","doi-asserted-by":"publisher","first-page":"e0268050","DOI":"10.1371\/journal.pone.0268050","volume":"17","author":"O Freund","year":"2022","unstructured":"Freund O, Tau L, Weiss TE, et al. Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era. PLoS ONE. 2022;17(5):e0268050. https:\/\/doi.org\/10.1371\/journal.pone.0268050.","journal-title":"PLoS ONE"},{"issue":"1","key":"1139_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12879-021-06156-x","volume":"21","author":"CDA Bichara","year":"2021","unstructured":"Bichara CDA, da Silva Gra\u00e7a Amoras E, Vaz GL, et al. Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population. BMC Infect Dis. 2021;21(1):443. https:\/\/doi.org\/10.1186\/s12879-021-06156-x.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1139_CR27","doi-asserted-by":"publisher","first-page":"23205","DOI":"10.1038\/s41598-021-02547-x","volume":"11","author":"TV Lerum","year":"2021","unstructured":"Lerum TV, Maltzahn NN, Aukrust P, et al. Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9. Sci Rep. 2021;11(1):23205. https:\/\/doi.org\/10.1038\/s41598-021-02547-x.","journal-title":"Sci Rep"},{"key":"1139_CR28","doi-asserted-by":"crossref","unstructured":"Jia X, Cao S, Lee AS, et al. Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome. JCI Insight. 2022;7(13).","DOI":"10.1172\/jci.insight.156713"},{"key":"1139_CR29","doi-asserted-by":"crossref","unstructured":"Guler SA, Ebner L, Aubry-Beigelman C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;57(4).","DOI":"10.1183\/13993003.03690-2020"},{"issue":"1","key":"1139_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12931-020-01429-6","volume":"21","author":"Y Huang","year":"2020","unstructured":"Huang Y, Tan C, Wu J, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020;21(1):163.","journal-title":"Respir Res"},{"issue":"7","key":"1139_CR31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S2213-2600(21)00174-0","volume":"9","author":"X Wu","year":"2021","unstructured":"Wu X, Liu X, Zhou Y, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9(7):747\u201354.","journal-title":"Lancet Respir Med"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01139-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01139-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01139-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:28:44Z","timestamp":1698784124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01139-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1139"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01139-5","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"27 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have any relevant conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Barzilai Medical Center review board. All included patients singed informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}